Andrew Arno
Director · Insight Molecular Diagnostics Inc.
- 2024
- Jul 7, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Andrew Arno files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BROADWOOD PARTNERS, L.P. - $5.69M in IMDX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Andrew Arno?
Andrew Arno is a corporate insider, tracked as Director of Insight Molecular Diagnostics Inc. (IMDX). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Andrew Arno last file a Form 4?
The most recent primary Form 4 on record is dated 7 July 2026, one of 9 filings going back to 2024.
Has Andrew Arno been buying or selling stock?
Recorded transactions: 1 open-market purchase ($26K) and 0 open-market sales across all tracked filings.
